SRStephan Ryser

Stephan Ryser

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stephan Ryser has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Werner Schlegel

    Foundation pour Recherches Médicales, University of Geneva, 64 av. de la Roseraie, Geneva, CH-1211, Switzerland

    2 shared publications
  • Edith Magnenat

    Ares-Serono, 14 ch. des Aulx, 1228 Plan-Les-Ouates, CH-1211 Geneva, Switzerland

    1 shared publication
  • Elisabeth Vial

    Ares-Serono, 14 ch. des Aulx, 1228 Plan-Les-Ouates, CH-1211 Geneva, Switzerland

    1 shared publication
  • Kinsey Maundrell

    Ares-Serono, 14 ch. des Aulx, 1228 Plan-Les-Ouates, CH-1211 Geneva, Switzerland

    1 shared publication
  • Silvia Tortola

    Foundation pour Recherches Médicales, University of Geneva, 64 av. de la Roseraie, Geneva, CH-1211, Switzerland

    1 shared publication

Latest Publications

  • MAP KINASE PHOSPHATASE-1 GENE EXPRESSION AND REGULATION IN NEUROENDOCRINE CELLS

    by Stephan Ryser, Silvia Tortola, Werner Schlegel

    Long-term cellular processes like proliferation, differentiation, and adaptive responses (e.g. neuronal plasticity) are initiated by the synthesis of immediate early gene (IEG) products which control the expression of late response genes. Immediate early genes encode for transcription factors, structural proteins, cytokines, and other regulatory proteins. One of the latter category of IEG products is the mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1), a dual specificity tyrosine phosphatase which inactivates the MAP kinase ERK in the nucleus. In GH4C1 neuroendocrine cells, MKP-1 is rapidly synthesised and translocated to the nucleus in response thyrotropin-releasing hormone (TRH) or epidermal growth factor (EGF). Regulation of MKP-1 gene expression in this cell line is controlled at the transcriptional level via a strong block to elongation in the exon 1 of the gene. After stimulation with TRH the block to elongation is released and gene transcription is completed. Nuclear run-on is ...


  • Reconstitution of caspase-mediated cell-death signalling in Schizosaccharomyces pombe

    by Stephan Ryser, Elisabeth Vial, Edith Magnenat, Werner Schlegel, Kinsey Maundrell

    Two pro-apoptotic proteases, caspase-1 and caspase-3, have been expressed as full-length proteins in the fission yeast Schizosaccharomyces pombe. Both proteins autoprocess to generate the corresponding active enzyme and both are lethal to the yeast cell. Lethality is due to catalytic activity since the expression of the inactive mutant forms of both caspases does not result in an obvious phenotype. Caspase-expressing yeast can be rescued by co-expression of the baculovirus protein p35, a known inhibitor of the caspase family. Co-expression of Bcl-2, another anti-apoptotic protein, does not prevent the cell death induced by either caspase. However, Bcl-2 is itself cleaved by both caspase-1 and caspase-3 at two adjacent recognition sites, YEWD31′A and DAGD34′V respectively, immediately downstream from the N-terminal BH4 domain, a region of Bcl-2 which is essential for its anti-apoptotic activity; similar cleavage of Bcl-2 by caspases has been demonstrated in mammalian cells. Hence, key elements of the apoptotic pathway can be reliably reconstituted in fission yeast, opening the way to exploit yeast in order to study the control of apoptosis. Furthermore, the activity of caspase-3, although not caspase-1, can be demonstrated in vitro using chromogenic substrates. This offers the possibility of using caspase-producing strains of yeast to screen for chemical inhibitors either in vivo or in vitro.